Cargando…

Long Journey of Sclerosant From the Esophagus to the Right Atrium

A 34-year-old man, who had been treated with an endoscopic injection of a mixture of n-butyl-2-cyanoacrylate (Histoacryl) and Lipiodol for control of variceal bleeding 6 months previously, presented with an intracardiac mass in the right atrium (RA). Two-dimensional echocardiography revealed an intr...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jin-Sun, Park, Jin-Ju, Lim, Seung-Kwan, Choi, Byoung-Joo, Choi, So-Yeon, Yoon, Myeong-Ho, Hwang, Gyo-Seung, Tahk, Seung-Jea, Shin, Joon-Han
Formato: Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957639/
https://www.ncbi.nlm.nih.gov/pubmed/20967150
http://dx.doi.org/10.4070/kcj.2010.40.9.468
Descripción
Sumario:A 34-year-old man, who had been treated with an endoscopic injection of a mixture of n-butyl-2-cyanoacrylate (Histoacryl) and Lipiodol for control of variceal bleeding 6 months previously, presented with an intracardiac mass in the right atrium (RA). Two-dimensional echocardiography revealed an intracardiac mass in the RA that appeared to extend from the inferior vena cava. The origin of the sclerosant was traced by computed tomography (CT). This is a very rare case in which the sclerosant migration route was demonstrated by CT scan. The findings of this case suggest that the systemic migration of sclerosant into an intracardiac chamber should be considered in patients with an intracardiac mass, especially with a history of previous sclerotherapy for variceal bleeding.